Having PAD was a predictor for further CV morbidity and mortality in the general population, patients with DM, and even those with CKD; however, studies regarding the relationship between the serum OPG level and PAD measured using ABI in patients on PD remained limited. The gene discussed is TNFRSF11B; the disease is peripheral arterial disease.